Is The Market Wrong About Regenbogen AG (FRA:RGB)?

It is hard to get excited after looking at Regenbogen’s (FRA:RGB) recent performance, when its stock has declined 17% over the past three months. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Specifically, we decided to study Regenbogen’s ROE in this article.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company’s success at turning shareholder investments into profits.

See our latest analysis for Regenbogen

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Regenbogen is:

16% = €1.5m ÷ €9.7m (Based on the trailing twelve months to December 2019).

The ‘return’ is the income the business earned over the last year. That means that for every €1 worth of shareholders’ equity, the company generated €0.16 in profit.

What Is The Relationship Between ROE And Earnings Growth?

We have already established that ROE serves as an efficient profit-generating gauge for a company’s future earnings. Depending on how much of these profits the company reinvests or “retains”, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don’t necessarily bear these characteristics.

Regenbogen’s Earnings Growth And 16% ROE

To start with, Regenbogen’s ROE looks acceptable. Even when compared to the industry average of 14% the company’s ROE looks quite decent. However, we are curious as to how Regenbogen’s decent returns still resulted in flat growth for Regenbogen in the past five years. We reckon that there could be some other factors at play here that’s limiting the company’s growth. These include low earnings retention or poor allocation of capital.

We then compared Regenbogen’s net income growth with the industry and found that the company’s growth figure is lower than the average industry growth rate of 6.8% in the same period, which is a bit concerning.

More

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. If you’re wondering about Regenbogen’s’s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Regenbogen Efficiently Re-investing Its Profits?

Regenbogen doesn’t pay any dividend, meaning that potentially all of its profits are being reinvested in the business. However, this doesn’t explain why the company hasn’t seen any growth. So there might be other factors at play here which could potentially be hampering growth. For example, the business has faced some headwinds.

Conclusion

Overall, we feel that Regenbogen certainly does have some positive factors to consider. However, given the high ROE and high profit retention, we would expect the company to be delivering strong earnings growth, but that isn’t the case here. This suggests that there might be some external threat to the business, that’s hampering its growth. So far, we’ve only made a quick discussion around the company’s earnings growth. To gain further insights into Regenbogen’s past profit growth, check out this visualization of past earnings, revenue and cash flows.

Story continues